Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell Ho

Showing results (111-120 of 143) with videos related to

Pageof 15
Sort By:
Nature Communications|September 22, 2023
Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumoursDan Li, Ruixue Wang, Tianyuzhou Liang, et al.
Journal for Immunotherapy of Cancer|April 9, 2021
Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular CarcinomaLuan Sun, Fang Gao, Zhanhui Gao, et al.
Molecular Cancer|October 28, 2006
Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumorsJennifer A A Gubbels, Jennifer Belisle, Masanori Onda, et al.
Molecular Pharmaceutics|May 9, 2015
Glypican-3 targeted human heavy chain antibody as a drug carrier for hepatocellular carcinoma therapyHirofumi Hanaoka, Tadanobu Nagaya, Kazuhide Sato, et al.
Molecular Cancer Therapeutics|November 2, 2021
Combination Therapy of Hepatocellular Carcinoma by GPC3-Targeted Bispecific Antibody and Irinotecan is Potent in Suppressing Tumor Growth in MiceXin Chen, Yanmin Chen, Rong Liang, et al.
Hepatology (Baltimore, Md.)|April 10, 2019
A Frizzled-Like Cysteine-Rich Domain in Glypican-3 Mediates Wnt Binding and Regulates Hepatocellular Carcinoma Tumor Growth in MiceNa Li, Liwen Wei, Xiaoyu Liu, et al.
Nature Communications|April 8, 2023
The IgG4 hinge with CD28 transmembrane domain improves V<sub>H</sub>H-based CAR T cells targeting a membrane-distal epitope of GPC1 in pancreatic cancerNan Li, Alex Quan, Dan Li, et al.
Journal for Immunotherapy of Cancer|January 11, 2023
Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastomaMing Sun, Yingying Cao, Reona Okada, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 18, 2025
Generation of Site-Specifically Labeled Affinity Reagents via Use of a Self-Labeling Single Domain AntibodyStanley Fayn, Swarnali Roy, Chino C Cabalteja, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Enteroviral epitope mimicry enables NK cell-mediated targeting of ASPH in hepatocellular carcinomaMan Hsin Hung, Qin Li, Limin Wang, et al.
Pageof 15

Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
Nature Communications|September 22, 2023
Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumoursDan Li, Ruixue Wang, Tianyuzhou Liang, et al.
Journal for Immunotherapy of Cancer|April 9, 2021
Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular CarcinomaLuan Sun, Fang Gao, Zhanhui Gao, et al.
Molecular Cancer|October 28, 2006
Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumorsJennifer A A Gubbels, Jennifer Belisle, Masanori Onda, et al.
Molecular Pharmaceutics|May 9, 2015
Glypican-3 targeted human heavy chain antibody as a drug carrier for hepatocellular carcinoma therapyHirofumi Hanaoka, Tadanobu Nagaya, Kazuhide Sato, et al.
Molecular Cancer Therapeutics|November 2, 2021
Combination Therapy of Hepatocellular Carcinoma by GPC3-Targeted Bispecific Antibody and Irinotecan is Potent in Suppressing Tumor Growth in MiceXin Chen, Yanmin Chen, Rong Liang, et al.
Hepatology (Baltimore, Md.)|April 10, 2019
A Frizzled-Like Cysteine-Rich Domain in Glypican-3 Mediates Wnt Binding and Regulates Hepatocellular Carcinoma Tumor Growth in MiceNa Li, Liwen Wei, Xiaoyu Liu, et al.
Nature Communications|April 8, 2023
The IgG4 hinge with CD28 transmembrane domain improves V<sub>H</sub>H-based CAR T cells targeting a membrane-distal epitope of GPC1 in pancreatic cancerNan Li, Alex Quan, Dan Li, et al.
Journal for Immunotherapy of Cancer|January 11, 2023
Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastomaMing Sun, Yingying Cao, Reona Okada, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 18, 2025
Generation of Site-Specifically Labeled Affinity Reagents via Use of a Self-Labeling Single Domain AntibodyStanley Fayn, Swarnali Roy, Chino C Cabalteja, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Enteroviral epitope mimicry enables NK cell-mediated targeting of ASPH in hepatocellular carcinomaMan Hsin Hung, Qin Li, Limin Wang, et al.
Pageof 15